Qube Research & Technologies (QRT)
KNSA icon

Qube Research & Technologies (QRT)’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.4M Sell
304,080
-382,773
-56% -$19.9M 0.02% 924
2026
Q1 		$33.1M Sell
686,853
-79,438
-10% -$3.52M 0.04% 606
2025
Q4 		$31.6M Buy
766,291
+76,403
+11% +$3.06M 0.03% 696
2025
Q3 		$26.8M Sell
689,888
-198,476
-22% -$6.45M 0.03% 755
2025
Q2 		$24.6M Buy
888,364
+653,236
+278% +$16.6M 0.03% 773
2025
Q1 		$5.22M Sell
235,128
-185,002
-44% -$3.81M 0.01% 1504
2024
Q4 		$8.31M Buy
420,130
+31,774
+8% +$725K 0.01% 1206
2024
Q3 		$9.71M Buy
+388,356
New +$9.46M 0.01% 1064
2024
Q2 		– Sell
-128,821
Closed -$2.54M – 4318
2024
Q1 		$2.54M Buy
128,821
+34,322
+36% +$670K ﹤0.01% 1617
2023
Q4 		$1.66M Buy
94,499
+17,562
+23% +$289K ﹤0.01% 1634
2023
Q3 		$1.34M Sell
76,937
-42,951
-36% -$724K ﹤0.01% 1592
2023
Q2 		$1.69M Sell
119,888
-6,802
-5% -$91K 0.01% 1114
2023
Q1 		$1.36M Buy
+126,690
New +$1.67M 0.01% 1170
2021
Q4 		– Sell
-32,141
Closed -$366K – 2758
2021
Q3 		$366K Buy
+32,141
New +$419K ﹤0.01% 1390
2020
Q3 		– Sell
-20,221
Closed -$515K – 1916
2020
Q2 		$515K Buy
+20,221
New +$422K 0.01% 1097

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Qube Research & Technologies (QRT)'s KNSA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Kiniksa Pharmaceuticals (KNSA) stake by 56% in Q2 2026, selling an estimated $19.9M and leaving 304,080 shares worth $19.4M. The position accounts for 0.02% of the portfolio, ranked #924.

Qube Research & Technologies (QRT) first reported a position in KNSA in Q2 2020 and has held it in 15 quarters since. The position peaked at $33.1M in Q1 2026. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Qube Research & Technologies (QRT) held 304,080 shares of Kiniksa Pharmaceuticals worth $19.4M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 382,773 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $19.9M.
  • Kiniksa Pharmaceuticals made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #924 holding.
  • Qube Research & Technologies (QRT) first reported a position in Kiniksa Pharmaceuticals in Q2 2020 and has held it in 15 quarters since.
  • Qube Research & Technologies (QRT)'s Kiniksa Pharmaceuticals position peaked at $33.1M in Q1 2026.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.